Abiopharma

Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Safehold Closes $45 Million Affordable Housing Ground Lease in Santa Cruz, California

Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Castellum to Present at Maxim Group Defense Tech and Domestic Supply Chain Virtual Conference on June 25

CBAK Energy Completes Redomiciliation to the Cayman Islands

Euroseas Ltd. Announces Annual Meeting of Shareholders

FedEx Reports Strong Fourth Quarter and Full-Year Results

Waterstone Financial Declares Regular Quarterly Cash Dividend

Willis Lease Finance Corporation Shareholders Deliver Resounding Approval of 3-for-1 Stock Split and All 2026 Proxy Proposals

VS-7375 Demonstrates Clinical Activity with a Favorable Safety and Tolerability Profile in TARGET-D 101 Phase 1/2 Clinical Trial in Patients with Advanced KRAS G12D-Mutated Solid Tumors